Photo by richardrschunemann from unsplash
The treatment of Helicobacter pylori usually fails due to their ability to form biofilms and resistance to antibiotics. This might potentially lead to gastric carcinoma and mucosa‐associated lymphoid tissue lymphoma.… Click to show full abstract
The treatment of Helicobacter pylori usually fails due to their ability to form biofilms and resistance to antibiotics. This might potentially lead to gastric carcinoma and mucosa‐associated lymphoid tissue lymphoma. In the present study, we elucidate the potential role of N‐acylhomoserine lactonase stabilized silver nanoparticles (AiiA‐AgNPs) in treating biofilms produced by H. pylori. AiiA‐AgNPs inhibited quorum sensing (QS) by degradation of QS molecules, thereby reducing biofilm formation, urease production, and altering cell surface hydrophobicity of H. pylori. AiiA‐AgNPs showed no cytotoxic effects on RAW 264.7 macrophages at the effective concentration (1–5 µM) of antibiofilm activity. In addition, AiiA‐AgNP in high concentration (80–100 µM) exhibited cytotoxicity against HCT‐15 carcinoma cells, depicting its therapeutic role in treating cancer.
Journal Title: Journal of Basic Microbiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!